Skip to main content

Ibutilide Pregnancy and Breastfeeding Warnings

Brand names: Corvert

Medically reviewed by Drugs.com. Last updated on Oct 4, 2024.

Ibutilide Pregnancy Warnings

This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.

US FDA pregnancy category: Not assigned.

Risk summary: Based on animal data, this drug may cause fetal harm; animal studies have revealed evidence of embryotoxicity.

Animal studies have revealed evidence of teratogenicity and embryolethality. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Ibutilide Breastfeeding Warnings

Use should be avoided.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

Does Ibutilide interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. (2001) "Product Information. Corvert (ibutilide)." Pharmacia and Upjohn
  2. (2025) "Product Information. Corvert (ibutilide)." Pfizer U.S. Pharmaceuticals Group

References for breastfeeding information

  1. (2001) "Product Information. Corvert (ibutilide)." Pharmacia and Upjohn
  2. (2025) "Product Information. Corvert (ibutilide)." Pfizer U.S. Pharmaceuticals Group

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer